These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 32652621)

  • 21. Mobile safe injecting facilities in Barcelona and Berlin.
    Dietze P; Winter R; Pedrana A; Leicht A; Majó I Roca X; Brugal MT
    Int J Drug Policy; 2012 Jul; 23(4):257-60. PubMed ID: 22464795
    [No Abstract]   [Full Text] [Related]  

  • 22. Take-home naloxone possession among people who inject drugs in rural West Virginia.
    Allen ST; White RH; O'Rourke A; Grieb SM; Kilkenny ME; Sherman SG
    Drug Alcohol Depend; 2019 Nov; 204():107581. PubMed ID: 31574407
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ODYSSEAS: supervised use of drugs versus bureaucracy in Greece.
    Malliori M; Galinaki S; Papakonstantinou AK
    Lancet Psychiatry; 2015 Feb; 2(2):e3. PubMed ID: 26359756
    [No Abstract]   [Full Text] [Related]  

  • 24. Rural Health Care Delivery Organizations and COVID-19: Major Challenges and Implications for Health Care Management Education and Training.
    Howard S; Counte M; Mikes J; Dybdal L; Linomaz J
    J Rural Health; 2021 Jan; 37(1):249-251. PubMed ID: 32643173
    [No Abstract]   [Full Text] [Related]  

  • 25. Community Perceptions of Comprehensive Harm Reduction Programs and Stigma Towards People Who Inject Drugs in Rural Virginia.
    Baker LS; Smith W; Gulley T; Tomann MM
    J Community Health; 2020 Apr; 45(2):239-244. PubMed ID: 31502098
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treating COVID-19 in Rural America.
    Dandachi D; Reece R; Wang EW; Nelson T; Rojas-Moreno C; Shoemaker DM
    J Rural Health; 2021 Jan; 37(1):205-206. PubMed ID: 32362035
    [No Abstract]   [Full Text] [Related]  

  • 27. Harm reduction and health services provided by syringe services programs in 2019 and subsequent impact of COVID-19 on services in 2020.
    Behrends CN; Lu X; Corry GJ; LaKosky P; Prohaska SM; Glick SN; Kapadia SN; Perlman DC; Schackman BR; Des Jarlais DC
    Drug Alcohol Depend; 2022 Mar; 232():109323. PubMed ID: 35124386
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lessons Learned: Pediatric Telemental Health in a Rural Medical Center in the Age of SARS-CoV-2.
    Satti K; Ojugbele O
    J Rural Health; 2021 Jan; 37(1):260-262. PubMed ID: 32845031
    [No Abstract]   [Full Text] [Related]  

  • 29. The prospect of implementing a Safer Injection Facility in San Francisco: perspectives of community stakeholders.
    Wenger LD; Arreola SG; Kral AH
    Int J Drug Policy; 2011 May; 22(3):239-41. PubMed ID: 21334185
    [TBL] [Abstract][Full Text] [Related]  

  • 30. COVID-19 During the Opioid Epidemic - Exacerbation of Stigma and Vulnerabilities.
    Jenkins WD; Bolinski R; Bresett J; Van Ham B; Fletcher S; Walters S; Friedman SR; Ezell JM; Pho M; Schneider J; Ouellet L
    J Rural Health; 2021 Jan; 37(1):172-174. PubMed ID: 32277731
    [No Abstract]   [Full Text] [Related]  

  • 31. A 21st-century Lazarus: the role of safer injection sites in harm reduction and recovery.
    Strathdee SA; Pollini RA
    Addiction; 2007 Jun; 102(6):848-9. PubMed ID: 17523973
    [No Abstract]   [Full Text] [Related]  

  • 32. Forecasted and Observed Drug Overdose Deaths in the US During the COVID-19 Pandemic in 2020.
    Cartus AR; Li Y; Macmadu A; Goedel WC; Allen B; Cerdá M; Marshall BDL
    JAMA Netw Open; 2022 Mar; 5(3):e223418. PubMed ID: 35311967
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Between Emergency Department Visits: The Role of Harm Reduction Programs in Mitigating the Harms Associated With Injection Drug Use.
    Macias-Konstantopoulos W; Heins A; Sachs CJ; Whiteman PJ; Wingkun NG; Riviello RJ
    Ann Emerg Med; 2021 May; 77(5):479-492. PubMed ID: 33579588
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Changing risk and presentation of overdose associated with consumption of street drugs at a supervised injection site in Vancouver, Canada.
    Notta D; Black B; Chu T; Joe R; Lysyshyn M
    Drug Alcohol Depend; 2019 Mar; 196():46-50. PubMed ID: 30665151
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fadi Meroueh: responding to the health needs of prisoners.
    Bull World Health Organ; 2021 Jan; 99(1):8-9. PubMed ID: 33658731
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Will Community Health Centers Survive COVID-19?
    Wright B; Fraher E; Holder MG; Akiyama J; Toomey B
    J Rural Health; 2021 Jan; 37(1):235-238. PubMed ID: 32415879
    [No Abstract]   [Full Text] [Related]  

  • 37. Overdose-Related Cardiac Arrests Observed by Emergency Medical Services During the US COVID-19 Epidemic.
    Friedman J; Beletsky L; Schriger DL
    JAMA Psychiatry; 2021 May; 78(5):562-564. PubMed ID: 33270086
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Community attitudes towards harm reduction services and a newly established needle and syringe automatic dispensing machine in an inner-city area of Sydney, Australia.
    White B; Haber PS; Day CA
    Int J Drug Policy; 2016 Jan; 27():121-6. PubMed ID: 26118798
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Services for drug users. Making a difference in many lives].
    Medellín JM
    Sidahora; 2005; ():12-7. PubMed ID: 16634157
    [No Abstract]   [Full Text] [Related]  

  • 40. A Descriptive Comparison of Substance Use Services in Recovery and Isolation Sites for People Experiencing Homelessness During the COVID-19 Pandemic, Boston and Toronto.
    Harris MTH; Young S; Barocas J; Bayoumi AM; Caudarella A; Laurence G; Tomanovich M; Komaromy M
    Public Health Rep; 2021; 136(5):532-537. PubMed ID: 34269625
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.